These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31046491)

  • 1. Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology.
    Drozdoff L; Klein E; Kalder M; Brambs C; Kiechle M; Paepke D
    Integr Cancer Ther; 2019; 18():1534735419846392. PubMed ID: 31046491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.
    Drozdoff L; Klein E; Kiechle M; Paepke D
    BMC Complement Altern Med; 2018 Sep; 18(1):259. PubMed ID: 30249217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions.
    Debes AM; Koenig A; Strobach D; Schinkoethe T; Forster M; Harbeck N; Wuerstlein R
    Breast Care (Basel); 2023 Oct; 18(5):327-335. PubMed ID: 37901050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy.
    Schmidt G; Mathes S; Klein E; Kiechle M; Paepke D
    J Evid Based Integr Med; 2020; 25():2515690X20949444. PubMed ID: 32808558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
    Loquai C; Dechent D; Garzarolli M; Kaatz M; Kaehler KC; Kurschat P; Meiss F; Stein A; Nashan D; Micke O; Muecke R; Muenstedt K; Stoll C; Schmidtmann I; Huebner J
    Med Oncol; 2016 May; 33(5):52. PubMed ID: 27090799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions from complementary and alternative medicine in patients with melanoma.
    Loquai C; Schmidtmann I; Garzarolli M; Kaatz M; Kähler KC; Kurschat P; Meiss F; Micke O; Muecke R; Muenstedt K; Nashan D; Stein A; Stoll C; Dechent D; Huebner J
    Melanoma Res; 2017 Jun; 27(3):238-242. PubMed ID: 28252553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
    Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.
    Zeller T; Muenstedt K; Stoll C; Schweder J; Senf B; Ruckhaeberle E; Becker S; Serve H; Huebner J
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):357-65. PubMed ID: 23099993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of complementary and alternative medicine by patients in routine care and the risk of interactions.
    Firkins R; Eisfeld H; Keinki C; Buentzel J; Hochhaus A; Schmidt T; Huebner J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):551-557. PubMed ID: 29356888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
    Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
    J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients.
    Paepke D; Wiedeck C; Hapfelmeier A; Karmazin K; Kiechle M; Brambs C
    Breast Care (Basel); 2020 Aug; 15(4):380-385. PubMed ID: 32982648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project.
    Yap KY; Kuo EY; Lee JJ; Chui WK; Chan A
    Support Care Cancer; 2010 Jul; 18(7):883-91. PubMed ID: 19756775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients.
    Von Gruenigen VE; White LJ; Kirven MS; Showalter AL; Hopkins MP; Jenison EL
    Int J Gynecol Cancer; 2001; 11(3):205-9. PubMed ID: 11437926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.
    Ben-Arye E; Schiff E; Steiner M; Keshet Y; Lavie O
    Int J Gynecol Cancer; 2012 Jan; 22(1):146-53. PubMed ID: 21912265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and implementing a complex Complementary and Alternative (CAM) nursing intervention for breast and gynecologic cancer patients undergoing chemotherapy--report from the CONGO (complementary nursing in gynecologic oncology) study.
    Klafke N; Mahler C; von Hagens C; Blaser G; Bentner M; Joos S
    Support Care Cancer; 2016 May; 24(5):2341-2350. PubMed ID: 26630949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the impact of herb-drug combinations used by cancer patients.
    Alsanad SM; Howard RL; Williamson EM
    BMC Complement Altern Med; 2016 Oct; 16(1):393. PubMed ID: 27756298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy.
    Sont OM; Rombouts MD; Crul M
    J Oncol Pharm Pract; 2024 Jun; 30(4):628-635. PubMed ID: 37259518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.
    Navo MA; Phan J; Vaughan C; Palmer JL; Michaud L; Jones KL; Bodurka DC; Basen-Engquist K; Hortobagyi GN; Kavanagh JJ; Smith JA
    J Clin Oncol; 2004 Feb; 22(4):671-7. PubMed ID: 14966090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies.
    Fasching PA; Thiel F; Nicolaisen-Murmann K; Rauh C; Engel J; Lux MP; Beckmann MW; Bani MR
    Support Care Cancer; 2007 Nov; 15(11):1277-1284. PubMed ID: 17333294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.
    Ben-Arye E; Dahly H; Keshet Y; Dagash J; Samuels N
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1825-1833. PubMed ID: 29980837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.